Published in Sleep on October 01, 1991
The socioeconomic impact of insomnia. An overview. Pharmacoeconomics (1996) 1.27
Zopiclone: is it a pharmacologic agent for abuse? Can Fam Physician (2007) 1.20
A comparison of the residual effects of zaleplon and zolpidem following administration 5 to 2 h before awakening. Br J Clin Pharmacol (1999) 1.09
Impact of insomnia on health-related quality of life. Pharmacoeconomics (1996) 0.83
Factors associated with long-term use of hypnotics among patients with chronic insomnia. PLoS One (2014) 0.81
Clinical management of patients with insomnia. The role of zopiclone. Pharmacoeconomics (1996) 0.77
Modelling the 1985 influenza epidemic in France. Stat Med (1988) 2.70
Prevalence of insomnia in a survey of 12,778 adults in France. J Sleep Res (2000) 2.37
Improvement of HbA1c and blood glucose stability in IDDM patients treated with lispro insulin analog in external pumps. Diabetes Care (1998) 1.12
A prospective study of the evolution of lamivudine resistance mutations in patients with chronic hepatitis B treated with lamivudine. J Viral Hepat (2006) 1.09
The effect of fluoxetine on anxiety and depression symptoms in cancer patients. Acta Psychiatr Scand (1996) 1.07
Rate dependence of sotalol-induced prolongation of ventricular repolarization during exercise in humans. Circulation (1991) 0.99
Alcohol or drug use and compliance with safer sex guidelines for STD/HIV infection. Results from the French National Survey on Sexual Behavior (ACSF) among heterosexuals. Analyse des Comportements Sexuels en France. Sex Transm Dis (1998) 0.99
Channelling of COX-2 inhibitors to patients at higher gastrointestinal risk but not at lower cardiovascular risk: the Cox2 inhibitors and tNSAIDs description of users (CADEUS) study. Pharmacoepidemiol Drug Saf (2007) 0.94
Haemodynamic adaptation two months after transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients. Gut (1996) 0.93
Activated factor X and thrombin formation triggered by tissue factor on endothelial cell matrix in a flow model: effect of the tissue factor pathway inhibitor. Blood (1994) 0.92
Short- and long-term hemodynamic effects of transjugular intrahepatic portosystemic shunts: a Doppler/manometric correlative study. AJR Am J Roentgenol (1995) 0.91
[Two years follow-up of a heroin users cohort treated with high dosage buprenorphine. Results of the SPESUB study (pharmacoepidemiologic follow-up of general practice Subutex)]. Rev Epidemiol Sante Publique (2000) 0.89
New phenotype of the cerebral autosomal dominant arteriopathy mapped to chromosome 19: migraine as the prominent clinical feature. J Neurol Neurosurg Psychiatry (1995) 0.88
Absolute bioavailability and electroencephalographic effects of conventional and extended-release formulations of venlafaxine in healthy subjects. J Clin Pharmacol (1998) 0.88
15-Lipoxygenase expression in smooth muscle cells from atherosclerotic rabbit aortas. Atherosclerosis (1995) 0.86
Safety, tolerability, pharmacokinetics and pharmacodynamics of ascending single and multiple doses of lecozotan in healthy young and elderly subjects. Br J Clin Pharmacol (2009) 0.85
The CADEUS study: methods and logistics. Pharmacoepidemiol Drug Saf (2007) 0.84
Treatment of acute hepatitis C with interferon alpha-2b: early initiation of treatment is the most effective predictive factor of sustained viral response. Aliment Pharmacol Ther (2004) 0.84
[Use of a structured diagnostic interview to identify depressive episodes in an epidemiologic study: a posteriori internal validation]. Rev Epidemiol Sante Publique (1999) 0.83
Synthesis of hydroxy fatty acids from linoleic acid by human blood platelets. Prostaglandins (1989) 0.83
Progress in understanding the pathophysiology of cerebral ischemia: the almitrine-raubasine approach. Clin Neuropharmacol (1990) 0.83
Comparative study of the effects of zopiclone (7.5 mg), zolpidem, flunitrazepam and a placebo on nocturnal cognitive performance in healthy subjects, in relation to pharmacokinetics. Eur Psychiatry (1995) 0.83
[Unexpected origin of recurrent ascites: apropos of 2 cases]. Acta Clin Belg (1997) 0.81
Lack of effect of mizolastine on the safety and pharmacokinetics of digoxin administered orally in repeated doses to healthy volunteers. Int J Clin Pharmacol Ther (1998) 0.81
A double-blind comparison of the long-term efficacy of a potassium channel opener and a calcium antagonist in stable angina pectoris. Eur Heart J (1993) 0.81
[Infections by Candida sp. in intensive care. Survey of French practices]. Presse Med (2003) 0.80
Chronic lymphocytic leukemia with portal hypertension and without liver involvement: a case report underlining the roles of increased spleno-portal blood flow and "protective" sinusoidal vasoconstriction. Acta Gastroenterol Belg (2004) 0.80
When patients report diseases that prescribers seem unaware of: discordance between patient and physician reporting of risk-related previous history in NSAID users from the CADEUS study. Clin Pharmacol Ther (2010) 0.80
Assessment of migraine severity using the MIGSEV scale: relationship to migraine features and quality of life. Cephalalgia (2004) 0.79
The HepCar registry: report on a one-year registration program of hepatocellular carcinoma (HCC) in Belgium. What is daily practice in HCC? Acta Gastroenterol Belg (2006) 0.79
[Comparison of the effects of zopiclone and triazolam on the sleep of normal subjects]. Encephale (1989) 0.79
Mesenterico-left intrahepatic portal vein shunt: original technique to treat symptomatic extrahepatic portal hypertension. Acta Gastroenterol Belg (1998) 0.78
Temporal profile of aminergic neurotransmitter release in striatal dialysates in rats with post-ischemic seizures. Exp Brain Res (1994) 0.78
Osseointegration of Brånemark fixtures using a single-step operating technique. A preliminary prospective one-year study in the edentulous mandible. Clin Oral Implants Res (1995) 0.78
Antidepressants and cognition: comparative effects of moclobemide, viloxazine and maprotiline. Psychopharmacology (Berl) (1992) 0.78
L-type voltage-dependent calcium channels do not modulate aminergic neurotransmitter release induced by transient global cerebral ischaemia: an in vivo microdialysis study in rat. Exp Brain Res (1993) 0.77
Cardiac beta-adrenoceptor sensitivity and Parkinson's disease. Fundam Clin Pharmacol (1991) 0.77
Controlled efficacy study of fluoxetine in dysthymia. Br J Psychiatry (1997) 0.77
Effect of bromazepam versus placebo on inhibition and waiting capacity in young women with traits of anxiety. Fundam Clin Pharmacol (1998) 0.76
[Treatment practices in the management of patients with bipolar disorder in France. The TEMPPO study]. Encephale (2011) 0.76
Effects of monohydroxylated fatty acids on arterial smooth muscle cell properties. Kidney Int Suppl (1992) 0.76
Synthesis of monohydroxylated fatty acids from linoleic acid by rat aortic smooth muscle cells and tissues: influence on prostacyclin production. J Lipid Res (1993) 0.76
Bioavailability of oral vitamin E formulations in adult volunteers and children with chronic cholestasis or cystic fibrosis. J Clin Pharm Ther (2009) 0.76
[Diagnostic and therapeutic management of ethylene glycol poisoning. Importance of crystalluria. Apropos of a case]. Nephrologie (1993) 0.75
Easy removal of migrated self-expanding esophageal metal stent using an endoloop device. Gastrointest Endosc (2000) 0.75
Effect of brain microdialysis on aminergic transmitter levels in repeated cerebral global transient ischemia in rat. J Neurosci Methods (1996) 0.75
[Sports activities and declared health status]. Sante Publique (1998) 0.75
[Impact of an information campaign on cardiovascular risk factors. 5-year results at the study town Epernon]. Presse Med (1999) 0.75
[4-month follow-up of 198 heroin addicts by general practitioners]. Rev Epidemiol Sante Publique (1997) 0.75
[Anxiolytic agents and hypnotic drugs in Bretagne. Pharmaco-epidemiological study]. Ann Med Interne (Paris) (1991) 0.75
[Zopiclone. Data of experimental pharmacology and clinical use]. Therapie (1993) 0.75
[Who are patients suffering from bipolar disorders in France? The TEMPPO survey: patients' sociodemographic and clinical characteristics data]. Encephale (2012) 0.75
[Apropos of 2 cases of mucocele with major ophthalmologic complications treated by endoscopic endonasal surgery]. Ann Otolaryngol Chir Cervicofac (1996) 0.75
Conventional antihypertensive drug therapy does not prevent the increase of pulse pressure with age. Hypertension (2001) 0.75
[Complete neuroleptic withdrawal in patients with schizophrenia with intense symptoms and resistant to treatment]. Encephale (1992) 0.75
[Cohort study of treated or not treated depressive workers: methodology and preliminary results]. Therapie (1997) 0.75
Pharmacology of the memory process. Arch Gerontol Geriatr Suppl (1989) 0.75
[Development of memory-improving drugs]. Ann Med Interne (Paris) (1990) 0.75
[The elderly healthy volunteer: a necessity]. Therapie (1994) 0.75
[Memory deficit in Parkinson's disease. Precocious aging of recall processes]. Presse Med (1992) 0.75
Comparison of three regimens of Parlodel-SRO in levodopa-treated parkinsonians: a randomized double-blind crossover study. Int J Clin Pharmacol Ther Toxicol (1991) 0.75
[Evaluation of tolerance during intravenous administration of low dose of isosorbide dinitrate in the treatment of unstable angina]. Arch Mal Coeur Vaiss (1992) 0.75
Oesophageal self expanding metal stents. Preliminary report about covered and non-covered types. Acta Gastroenterol Belg (2001) 0.75
[Randomized double-blind comparative study of minaprine (200mg/j) and of placebo on memory loss]. Therapie (1996) 0.75
[Compliance with hormone replacement therapy in menopausal women: results of a two-year prospective French study comparing transdermal treatment with fixed oral combination therapy]. Gynecol Obstet Fertil (2003) 0.75
[Pharmacology of cellular ischemia]. J Mal Vasc (1992) 0.75
Choosing a target for cognitive enhancers. Clin Ther (1990) 0.75
The rationale for using ursodeoxycholic acid in chronic liver disease. Acta Gastroenterol Belg (1991) 0.75
Endoscopic therapy of Barrett's oesophagus: critical review. Acta Gastroenterol Belg (2000) 0.75
[Not Available]. Ann Genet Sel Anim (1975) 0.75
[Study of 2 job positions in an electric light factory (testing of spirals and drawing of filaments)]. Rev Med Suisse Romande (1968) 0.75